Medical Animation Parkinsons Disease

New Pathway To Parkinson's And Alzheimer's Diseases
Although their genetic underpinnings differ, Alzheimer's disease, Parkinson's disease and Huntington's disease are all characterized by the untimely death of brain cells...

Study Identifies Molecular Mechanism Triggering Parkinson's Disease
Scientists at the Stanford University School of Medicine have identified a molecular pathway responsible for the death of key nerve cells whose loss causes Parkinson's disease. This discovery not only may explain how a genetic mutation linked to Parkinson's causes the cells' death, but could also open the door to new therapeutic approaches for the malady...

REM Sleep Disorder Could Be Early Warning Of Parkinson's, Dementia That Develops Decades Later
American neurologists and sleep experts suggest in a recent study that rapid eye movement (REM) sleep behavior disorder could be an early sign of Parkinson's disease or dementia that develops up to 50 years later. You can read how neurologist and sleep specialist Dr Bradley F...

Envoy To Seek New Parkinson's Disease Therapy With Scripps
Envoy Therapeutics Inc., a recently formed drug discovery company, announced that it has begun a research collaboration with The Scripps Research Institute to identify new drugs for Parkinson's disease (PD) that have greater efficacy and safety compared to current therapies...

Helping Neurons Fix Themselves In Parkinson's Patients
A Michigan State University researcher is working to uncover how a protein known as parkin may help nerve cells fight off damage from Parkinson's disease, a strategy that could lead to new therapies for the degenerative ailment...

The Neurons That Tell You To Quit
The basal ganglia is a series of highly connected brain areas localised deep in the cerebral cortex that recently has attracted interest of neuroscientists when it was linked to learning, and discovered to be affected in a number of disorders of the addictive and obsessive spectrum, but also in Parkinson's disease (PD)...

New Partnership With Open-Access Journal Molecular Neurodegeneration Announced By American Health Assistance Foundation
The American Health Assistance Foundation (AHAF)has announced a new partnership with BioMed Central's open access journal, Molecular Neurodegeneration (MN) in which the publication will be the official open access journal of AHAF...

Every Action Has A Beginning And An End (And It's All In Your Brain)
Rui Costa, Principal Investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciência (Portugal), and Xin Jin, of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (USA), describe in the latest issue of the journal Nature, that the activity of certain neurons in the brain can signal the initiation and terminatio...

New Findings On Troubling Side Effects Of Parkinson's Medication
One in every 100 elderly people suffers from Parkinson's disease, a disease of the nervous system with symptoms including stiffness and shaking. The standard medication used to treat Parkinson's is Levodopa, a drug that initially has major benefits but can later also produce serious side effects in the form of involuntary, jerky movements...

The Cause Of Parkinson's Disease May Be Revealed With The Help Of Skin Cells
Researchers are applying new stem cell technology to use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson's disease, the UK National Stem Cell Network (UKNSCN) annual science meeting heard...

Possible Link Between Low Vitamin D Levels And Parkinson's Disease
A new study on vitamin D levels and Parkinson's disease risk points to the need for further research on whether vitamin D supplements can protect against the movement disorder, according to an editorial in the July 2010 issue of Archives of Neurology...

Focus On Gait Disorders And Falls In Parkinson's Disease
Many of the symptoms of Parkinson disease can be alleviated with drugs that target dompamine, a chemical in the brain that is involved in nerve cell communication and therefore known as a neurotransmitter. However, such drugs do not improve the gait disorders and falls that commonly affect individuals with severe and advanced forms of Parkinson disease...

Parkinson's Patients More Likely To Stick With Certain 'Add-On' Drugs
Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson's disease, one might be the most effective, according to a new review. People with Parkinson's disease often initially experience tremors, stiffness, slowed movement or difficulty with balance and coordination...

Half A Million Britons Volunteer For World's Most Detailed Health Study
Half a million Britons have volunteered to take part in the world's most detailed health study: they have given samples, been weighed, measured, answered health and lifestyle questions, and agreed to have their health followed for the next 30 years...

Breaching The Blood/Brain Barrier To Improve Treatment For Neurodegenerative Diseases
The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood (HUCB) cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multi...